Ferring International Center SA-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Ferring International Center SA - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013475
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月28日
◆ページ数:51
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スイス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Ferring International Center SA (Ferring) researches, develops and markets pharmaceutical products. The company offers pharmaceutical products in the fields of reproductive health, gastroenterology, endocrinology, urology and orthopedics. Some of the marketed products include Rekovelle (follitropin delta), for controlled ovarian stimulation; Menopur (HP-hMG) for female and male infertility; Firmagon (degarelix) for prostate cancer; and Pentasa (mesalazine) for inflammatory bowel diseases. Its pipeline products encompass FE 999310 for infertility; FE 202767 for Lactation; Testavan for male hypogonadism; and Prefix for lumbar spine fusion, among others. Ferring conducts research and development on biotechnology derived medicines such as recombinant proteins and other biologics. It has production facilities in Argentina, Denmark, Germany, China, the Czech Republic, India, Scotland, Switzerland, Israel, Mexico, and a manufacturing site in the US. Ferring is headquartered at Saint-Prex, Switzerland.

Ferring International Center SA – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Ferring International Center SA, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6
Ferring International Center SA, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7
Ferring International Center SA, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8
Ferring International Center SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 9
Ferring International Center SA, Medical Devices Deals, 2011 to YTD 2017 10
Ferring International Center SA, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 11
Ferring International Center SA, Pharmaceuticals & Healthcare, Deal Details 13
Asset Purchase 13
Ferring International Center Acquire Ex-US Vitaros Assets and Rights from Apricus Biosciences 13
Ferring Pharma Acquires Global Rights to Milprosa from Teva Women’s Health 15
Ferring Pharma to Acquire Novel Drug Delivery Technology from CTCBIO 16
Ferring Pharma Acquires Assets from BioSurface Engineering 17
Ferring Pharma Acquires Ddavp from Sanofi 18
Ferring International To Acquire Assets Of Al-Kindi Pharma For US$6 Million 19
Partnerships 20
LIDDS Enters into Research Agreement with Ferring Pharma 20
Ferring International and Alrise Biosystems Enter into Co-Development Agreement 21
Ferring Pharma Enters into Agreement with CD Investments 22
Ferring Pharma Enters into Partnership with ICF 23
Ferring Pharma Enters into Agreement with Intralytix 24
Ferring International Center Enters into Agreement with Ache Laboratorios Farmaceuticos 25
Ferring Pharma Enters into Co-Development Agreement with Karolinska Institutet 26
Apricus Biosciences Extends Distribution Agreement with Ferring Pharma 27
Ferring Pharma Enters into Co-Development Agreement with Roche 28
Ferring Pharma And Merck Enter Into Agreement With World Health Organization For Anti-Bleeding Drug 29
Ferring Pharma Enters Into Co-Promotion Agreement With Kyowa Hakko For Desmopressin Acetate 30
Licensing Agreements 31
Ferring International Enters into Licensing Agreement with Enteris BioPharma 31
Ferring International Enters into Licensing Agreement with IMAB 32
Ferring Pharma Enters into Licensing Agreement with Seikagaku 33
Ferring Pharma Enters into Licensing Agreement with Cosmo Pharma 34
Levo Therapeutics to Enter into Licensing Agreement with Ferring Pharma 35
TxCell Enters into Licensing Agreement with Ferring International for Ovasave 36
SciGen Expands Its Licensing Agreement With Ferring And Bio-Technology General 38
Acquisition 39
Ferring Pharma Acquires Cytokine PharmaSciences And Controlled Therapeutics 39
Ferring International Center SA – Key Competitors 40
Ferring International Center SA – Key Employees 41
Ferring International Center SA – Locations And Subsidiaries 43
Head Office 43
Other Locations & Subsidiaries 43
Recent Developments 47
Corporate Communications 47
Oct 02, 2017: Ferring appoints Klaus Dugi as Executive Vice President and Chief Medical Officer 47
May 23, 2017: Ferring commits $10 million to March of Dimes to expand research needed to end preterm birth 48
Apr 03, 2017: Ferring appoints Dominic Moorhead as Executive Vice President and Chief Financial Officer 49
Government and Public Interest 50
Jun 21, 2016: Ferring demonstrates commitment to R&D investment through expanded Innovation Grants Program 50
Appendix 51
Methodology 51
About GlobalData 51
Contact Us 51
Disclaimer 51

List of Tables
Ferring International Center SA, Pharmaceuticals & Healthcare, Key Facts, 2015 2
Ferring International Center SA, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6
Ferring International Center SA, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7
Ferring International Center SA, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8
Ferring International Center SA, Deals By Therapy Area, 2011 to YTD 2017 9
Ferring International Center SA, Medical Devices Deals, 2011 to YTD 2017 10
Ferring International Center SA, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 11
Ferring International Center Acquire Ex-US Vitaros Assets and Rights from Apricus Biosciences 13
Ferring Pharma Acquires Global Rights to Milprosa from Teva Women's Health 15
Ferring Pharma to Acquire Novel Drug Delivery Technology from CTCBIO 16
Ferring Pharma Acquires Assets from BioSurface Engineering 17
Ferring Pharma Acquires Ddavp from Sanofi 18
Ferring International To Acquire Assets Of Al-Kindi Pharma For US$6 Million 19
LIDDS Enters into Research Agreement with Ferring Pharma 20
Ferring International and Alrise Biosystems Enter into Co-Development Agreement 21
Ferring Pharma Enters into Agreement with CD Investments 22
Ferring Pharma Enters into Partnership with ICF 23
Ferring Pharma Enters into Agreement with Intralytix 24
Ferring International Center Enters into Agreement with Ache Laboratorios Farmaceuticos 25
Ferring Pharma Enters into Co-Development Agreement with Karolinska Institutet 26
Apricus Biosciences Extends Distribution Agreement with Ferring Pharma 27
Ferring Pharma Enters into Co-Development Agreement with Roche 28
Ferring Pharma And Merck Enter Into Agreement With World Health Organization For Anti-Bleeding Drug 29
Ferring Pharma Enters Into Co-Promotion Agreement With Kyowa Hakko For Desmopressin Acetate 30
Ferring International Enters into Licensing Agreement with Enteris BioPharma 31
Ferring International Enters into Licensing Agreement with IMAB 32
Ferring Pharma Enters into Licensing Agreement with Seikagaku 33
Ferring Pharma Enters into Licensing Agreement with Cosmo Pharma 34
Levo Therapeutics to Enter into Licensing Agreement with Ferring Pharma 35
TxCell Enters into Licensing Agreement with Ferring International for Ovasave 36
SciGen Expands Its Licensing Agreement With Ferring And Bio-Technology General 38
Ferring Pharma Acquires Cytokine PharmaSciences And Controlled Therapeutics 39
Ferring International Center SA, Key Competitors 40
Ferring International Center SA, Key Employees 41
Ferring International Center SA, Other Locations 43
Ferring International Center SA, Subsidiaries 43

★海外企業調査レポート[Ferring International Center SA-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • First Philippine Holdings Corp (FPH):企業の財務・戦略的SWOT分析
    First Philippine Holdings Corp (FPH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Konica Minolta, Inc. (4902)-医療機器分野:企業M&A・提携分析
    Summary Konica Minolta, Inc. (Konica Minolta) develops, manufactures and sells printing systems and solutions for production print professionals. The company’s product portfolio includes multi-functional peripherals (MFPs), printers, equipment for production print systems and graphic arts, equipment …
  • MetGen Oy-製薬・医療分野:企業M&A・提携分析
    Summary MetGen Oy (MetGen) is a manufacturer and distributor of enzymatic solutions. The company provides metzyme, an industrial and natural catalysts used for accelerating chemical reactions. Its enzymatic solutions find applications in various processes such as mechanical processes, lignocellulosi …
  • Korea Development Bank:企業の戦略・SWOT・財務情報
    Korea Development Bank - Strategy, SWOT and Corporate Finance Report Summary Korea Development Bank - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • GW Pharmaceuticals Plc (GWPH):企業の財務・戦略的SWOT分析
    GW Pharmaceuticals Plc (GWPH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • GHD Pty Ltd:企業の戦略・SWOT・財務分析
    GHD Pty Ltd - Strategy, SWOT and Corporate Finance Report Summary GHD Pty Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • YTL Power International Bhd (YTLPOWR):企業の財務・戦略的SWOT分析
    YTL Power International Bhd (YTLPOWR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an …
  • Biodesy Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Biodesy Inc (Biodesy) is a drug discovery company that develops and offers products for detecting conformational change in proteins and other biological molecules. The company provides products such as delta system, delta assay and screening kits, and delta software, among others. It also de …
  • Eckert & Ziegler Strahlen- und Medizintechnik AG (EUZ):企業の財務・戦略的SWOT分析
    Summary Eckert & Ziegler Strahlen- und Medizintechnik AG (Eckert & Ziegler) is a medical device company that offers isotope technology products. The company offers radiation therapy, isotope and radio-pharma products. It provides radiation therapy products for Brachytherapy, a minimally invasive pro …
  • NLC India Ltd (NLCINDIA):企業の財務・戦略的SWOT分析
    NLC India Ltd (NLCINDIA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Thames Water Utilities Ltd:企業の戦略・SWOT・財務情報
    Thames Water Utilities Ltd - Strategy, SWOT and Corporate Finance Report Summary Thames Water Utilities Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Mustek Ltd (MST):企業の財務・戦略的SWOT分析
    Mustek Ltd (MST) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Dairyland Power Cooperative:企業の戦略的SWOT分析
    Dairyland Power Cooperative - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major product …
  • KARL STORZ GmbH & Co KG-医療機器分野:企業M&A・提携分析
    Summary KARL STORZ GmbH & Co KG (Karl Storz) is a manufacturer and distributor of endoscopes, surgical devices and medical instruments. The company offers rigid and flexible endoscopes, instruments for the field of human medicine used for neurosurgery; oral and maxillofacial surgery; ear, nose, and …
  • Nordea Private Banking:企業の戦略・SWOT・財務情報
    Nordea Private Banking - Strategy, SWOT and Corporate Finance Report Summary Nordea Private Banking - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Genel Energy Plc (GENL):企業の財務・戦略的SWOT分析
    Genel Energy Plc (GENL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Premera Blue Cross:企業の戦略的SWOT分析
    Premera Blue Cross - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • ImmusanT Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary ImmusanT Inc (ImmusanT) is a clinical stage biotechnology company that discovers, develops and delivers peptide-based immune therapies for the treatment of patients with autoimmune diseases. The company develops its therapeutic vaccines using its epitope-specific immuno-therapy (ESIT) platfo …
  • MDU Resources Group Inc Oil & Gas Exploration and Production Operations and Cost Analysis – 2017
    MDU Resources Group Inc Oil & Gas Exploration and Production Operations and Cost Analysis - 2017 Summary MDU Resources Group, Inc. (MDU) is an energy, and construction materials and services company. It mines aggregates and markets crushed stone, sand, gravel and related construction materials. The …
  • Alkem Laboratories Ltd (ALKEM):製薬・医療:M&Aディール及び事業提携情報
    Summary Alkem Laboratories Ltd (Alkem) is a pharmaceutical company that develops, manufactures and markets generic and specialty pharmaceutical products. The company’s products include active pharmaceutical ingredients, generic products, branded products and nutraceuticals. Alkem provides drugs for …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆